With all female patients in its groundbreaking clinical feasibility study reaching six-month primary endpoints, UroMems' UroActive System marks a transformative step in treating stress urinary incontinence. The AI-powered smart implant, designed to enhance patient quality of life, is now paving the way for expanded adoption in the U.S. and Europe. ...
With groundbreaking ultrasound-based solutions for brain cancer and drug-resistant epilepsy, NaviFUS expands its global impact through strategic industry collaborations, clinical breakthroughs, and partnerships with leading healthcare innovators....
LiS Academy, an independent academic forum led by top oncologists, aims to enhance awareness and adoption of liquid biopsies for personalized cancer care in India....
The U.S. FDA has approved Merilog (insulin-aspart-szjj), Sanofi’s biosimilar to Novolog, marking a significant step toward expanding access to affordable insulin. The approval strengthens competition in the diabetes treatment market, offering a new rapid-acting insulin option for millions of patients. ...
Clinical Symposium held on “Deeper Insights in Haematology”; Erba H7100 brings hope for early and accurate diagnosis of blood disorders...
Merger combines ultra-sensitive blood and tissue protein analysis into a unified platform. ...
With symptoms mimicking common respiratory illnesses, Human Metapneumovirus (HMNPV) is placing vulnerable populations at risk and straining healthcare systems. Learn the key precautions to stay safe....
